BRL 15572

specific for h5-HT(1D) receptors; structure in first source

Also Known As:

3-(4-(3-chlorophenyl)piperazin-1-yl)-1,1-diphenyl-2-propanol; BRL-15572; 1-Piperazineethanol, 4-(3-chlorophenyl)-alpha-(diphenylmethyl)-

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Aswar, Urmila: 1 article (04/2015)
2.	Bobade, Vijeta: 1 article (04/2015)
3.	Bodhankar, Subhash L: 1 article (04/2015)
4.	Thakurdesai, Prasad: 1 article (04/2015)
5.	Vishwaraman, Mohan: 1 article (04/2015)
6.	Argüelles, Carlos F: 1 article (06/2013)
7.	Godínez-Chaparro, Beatriz: 1 article (06/2013)
8.	Granados-Soto, Vinicio: 1 article (06/2013)
9.	López-Santillán, Francisco J: 1 article (06/2013)
10.	Villalón, Carlos M: 1 article (06/2013)

1.	Hyperalgesia 06/13/2013 - "Given alone, SB 224289 or BRL 15572 did not modify per se the long-lasting secondary allodynia and hyperalgesia. " 04/01/2015 - "The interaction of INDCA with selective 5-HT1A, 5-HT1B, and 5-HT1D receptor antagonists (NAN-190, Isamoltane hemifumarate, and BRL-15572 respectively) against NTG-induced hyperalgesia was also evaluated. "
2.	Bradycardia 11/01/2007 - "BRL-15572 (2 microg/kg), a selective 5-HT(1D) receptor antagonist, inhibited the action of L-694,247 (50 microg/kg), a selective agonist for the non-rodent 5-HT(1B) and 5-HT(1D) receptors, on the vagally induced bradycardia. "

1.	5-HT1D Serotonin Receptor
2.	SB 22489G
3.	L 694247
4.	1- (2- methoxyphenyl)- 4- (4- (2- phthalimido)butyl)piperazine
5.	isamoltane